Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Alzheimer's Disease

Free Subscription 05.11.2018 1 Alzheimer Dis Assoc Disord 1 BMC Geriatr 1 Curr Alzheimer Res 4 Dement Geriatr Cogn Disord 5 J Alzheimers Dis 1 J Neural Transm (Vienna) 2 J Neurol 1 Neurochem Res 1 Neurosci Lett 1 PLoS Genet 2 PLoS One 1 Proc Natl Acad Sci U S A 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Alzheimer Dis Assoc Disord

1. BESSER L, Kukull W, Knopman DS, Chui H, et al
   Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set.
   Alzheimer Dis Assoc Disord. 2018 Oct 29. doi: 10.1097/WAD.0000000000000279.
   PubMed     Text format     Abstract available
   
   

   
   BMC Geriatr

2. HILL NL, Mogle J
   Alzheimer's disease risk factors as mediators of subjective memory impairment and objective memory decline: protocol for a construct-level replication analysis.
   BMC Geriatr. 2018;18:260.
   PubMed     Text format     Abstract available
   
   

   
   Curr Alzheimer Res

3. ARTUSO V, Benussi L, Ghidoni R, Moradi-Bachiller S, et al
   Asymptomatic carriers of presenilin-1 E318G variant show no cerebrospinal fluid biochemical signs suggestive of Alzheimer's disease in a family with late-onset dementia.
   Curr Alzheimer Res. 2018 Oct 31. pii: CAR-EPUB-94168.
   PubMed     Text format     Abstract available
   
   

   
   Dement Geriatr Cogn Disord

4. KONIG A, Linz N, Troger J, Wolters M, et al
   Fully Automatic Speech-Based Analysis of the Semantic Verbal Fluency Task.
   Dement Geriatr Cogn Disord. 2018;45.
   PubMed     Text format     Abstract available
   
   
5. KNIGHT R, Khondoker M, Magill N, Stewart R, et al
   A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia.
   Dement Geriatr Cogn Disord. 2018;45.
   PubMed     Text format     Abstract available
   
   
6. BORG C, Bouazza Z, Godeau M, Getenet JC, et al
   Effect of Emotion and Type of Encoding on Memory for Actions: Verbal and Subject-Performed Tasks.
   Dement Geriatr Cogn Disord. 2018;45.
   PubMed     Text format     Abstract available
   
   
7. MECCA AP, Michalak HR, McDonald JW, Kemp EC, et al
   Sleep Disturbance and the Risk of Cognitive Decline or Clinical Conversion in the ADNI Cohort.
   Dement Geriatr Cogn Disord. 2018;45.
   PubMed     Text format     Abstract available
   
   

   
   J Alzheimers Dis

8. LIGUORI C, Mercuri NB, Nuccetelli M, Izzi F, et al
   Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms.
   J Alzheimers Dis. 2018 Oct 25. pii: JAD180769. doi: 10.3233/JAD-180769.
   PubMed     Text format     Abstract available
   
   
9. MADRID A, Hogan KJ, Papale LA, Clark LR, et al
   DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer's Disease.
   J Alzheimers Dis. 2018 Oct 22. pii: JAD180592. doi: 10.3233/JAD-180592.
   PubMed     Text format     Abstract available
   
   
10. COX KL, Cyarto EV, Ellis KA, Ames D, et al
    A Randomized Controlled Trial of Adherence to a 24-Month Home-Based Physical Activity Program and the Health Benefits for Older Adults at Risk of Alzheimer's Disease: The AIBL Active-Study.
    J Alzheimers Dis. 2018 Oct 26. pii: JAD180521. doi: 10.3233/JAD-180521.
    PubMed     Text format     Abstract available
    
    
11. DI LORENZO F, Ponzo V, Motta C, Bonni S, et al
    Impaired Spike Timing Dependent Cortico-Cortical Plasticity in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018 Oct 22. pii: JAD180503. doi: 10.3233/JAD-180503.
    PubMed     Text format     Abstract available
    
    
12. NASOOHI S, Parveen K, Ishrat T
    Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers.
    J Alzheimers Dis. 2018 Oct 23. pii: JAD180735. doi: 10.3233/JAD-180735.
    PubMed     Text format     Abstract available
    
    

    
    J Neural Transm (Vienna)

13. MARSHE VS, Gorbovskaya I, Kanji S, Kish M, et al
    Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature.
    J Neural Transm (Vienna). 2018 Oct 31. pii: 10.1007/s00702-018-1934.
    PubMed     Text format     Abstract available
    
    

    
    J Neurol

14. WEI H, Zhu X, Li Y
    Application value of serum biomarkers for choosing memantine therapy for moderate AD.
    J Neurol. 2018;265:1844-1849.
    PubMed     Text format     Abstract available
    
    
15. DE SIMONE MS, Perri R, Fadda L, Caltagirone C, et al
    Predicting progression to Alzheimer's disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests.
    J Neurol. 2018 Nov 1. pii: 10.1007/s00415-018-9108.
    PubMed     Text format     Abstract available
    
    

    
    Neurochem Res

16. ROWLAND HA, Hooper NM, Kellett KAB
    Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells.
    Neurochem Res. 2018 Nov 1. pii: 10.1007/s11064-018-2663.
    PubMed     Text format     Abstract available
    
    

    
    Neurosci Lett

17. OTA M, Matsuo J, Ishida I, Takano H, et al
    Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease.
    Neurosci Lett. 2018 Oct 24. pii: S0304-3940(18)30730.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Genet

18. RATHORE N, Ramani SR, Pantua H, Payandeh J, et al
    Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer's disease.
    PLoS Genet. 2018;14:e1007427.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

19. BARTHOLD D, Joyce G, Wharton W, Kehoe P, et al
    The association of multiple anti-hypertensive medication classes with Alzheimer's disease incidence across sex, race, and ethnicity.
    PLoS One. 2018;13:e0206705.
    PubMed     Text format     Abstract available
    
    
20. KATSEL P, Roussos P, Beeri MS, Gama-Sosa MA, et al
    Parahippocampal gyrus expression of endothelial and insulin receptor signaling pathway genes is modulated by Alzheimer's disease and normalized by treatment with anti-diabetic agents.
    PLoS One. 2018;13:e0206547.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

21. PRADO LIMA MG, Schimidt HL, Garcia A, Dare LR, et al
    Environmental enrichment and exercise are better than social enrichment to reduce memory deficits in amyloid beta neurotoxicity.
    Proc Natl Acad Sci U S A. 2018;115:E2403-E2409.
    PubMed     Text format     Abstract available
    
    

    
    Rev Neurol (Paris)

22. KOSKAS P, Pons-Peyneau C, Houenou-Quenum N, Romdhani M, et al
    Factors influencing time between onset of signs/symptoms and referral for dementia in elderly outpatients.
    Rev Neurol (Paris). 2018;174.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: